ANGIODYNAMICS EXPANDS PTA BALLOON DILATATION CATHETER
PORTFOLIO WITH INTRODUCTION OF PROFILER®
QUEENSBURY, N.Y.
May 1, 2007—AngioDynamics, Inc. (NASDAQ: ANGO), today
announced the introduction of its Profiler® Balloon Dilatation
Catheter in the U.S. market. This new low profile balloon catheter is indicated
for general percutaneous transluminal angioplasty (PTA) of the iliac, femoral,
and renal arteries and for the treatment of obstructive lesions of native or
synthetic arteriovenous dialysis fistulae.
PTA, an alternative to open
vascular surgery, is a procedure used to restore blood flow through narrowed
arteries that can be caused by congenital factors or as a result of
atherosclerotic disease. PTA involves inserting a balloon catheter into a narrow or
occluded blood vessel to recanalize and dilate the vessel by inflating the
balloon. It is most commonly used to treat narrowing in the leg arteries, and
can also be used to treat narrowing in veins.
“The development of low profile PTA
balloon technology allows physicians to perform angioplasty in a less-invasive
manner, which improves the overall quality of patient care,” commented Dr. John
Aruny, Associate Professor and Co-Chief,
Vascular and Interventional Radiology at Yale University School of Medicine. “This device, with its low profile
configuration, is an excellent example of a new technology that limits the size
of the introducer sheath to 5F while allowing inflation diameters up to 8mm.
The ability to work through smaller sheaths will directly contribute to
lessening puncture site morbidity,” added Dr. Aruny.
AngioDynamics’ Profiler offers a broad range of low profile PTA balloons, with
configurations of up to 8mm x 4cm balloons compatible with 5F sheaths, which
provide access to small vessels, tortuous anatomy, and tight stenotic lesions.
Additionally, the Profiler family offers a line of 9mm and 10mm balloons that
are compatible with a 6F sheath.
“The Profiler is an exciting new addition
to our PTA product line and fits with AngioDynamics’ strategy of providing
innovative products that improve patient outcomes, care and comfort,” commented
Eamonn P. Hobbs, AngioDynamics’ president and chief executive officer. “Along
with the recent launch of the Smart Port™ CT, we continue to build our market
opportunity through an increasingly diverse range of technologies.”
About
AngioDynamics
AngioDynamics,
Inc. is a leading provider of innovative medical devices used by interventional
radiologists, surgeons, and other physicians for the minimally invasive
treatment of cancer and peripheral vascular
disease. The Company's diverse product line includes market-leading
radiofrequency ablation systems, vascular access products, angiographic
products and accessories, dialysis products, angioplasty products, drainage
products, thrombolytic products, embolization products and venous products.
More information is available at www.angiodynamics.com.
Safe Harbor
The
statements made in this document contain certain forward-looking statements
that involve a number of risks and uncertainties. Words such as
"expects," "intends," "anticipates,"
"plans," "believes," "seeks,"
"estimates," or variations of such words and similar expressions, are
intended to identify such forward-looking statements. Investors are cautioned
that actual events or results may differ from the Company's expectations. In
addition to the matters described above, the ability of the Company to develop
its products, future actions by the FDA or other regulatory agencies, results
of pending or future clinical trials, overall economic conditions, general
market conditions, market acceptance, foreign currency exchange rate
fluctuations, the effects on pricing from group purchasing organizations and
competition, as well as the risk factors listed from time to time in the SEC
filings of AngioDynamics, Inc., including but not limited to its Annual Report
on Form 10-K for the year ended June 3, 2006, may affect the actual results
achieved by the Company.
AngioDynamics, Inc.
D. Joseph Gersuk
(800) 772-6446 x1608
jgersuk@AngioDynamics.com
EVC
Group, Inc.
Jennifer Beugelmans/Doug Sherk
(646)
201-5447
jbeugelmans@evcgroup.com
dsherk@evcgroup.com
EVC
Group, Inc.
Steve DiMattia
(646)
201-5445
sdimattia@evcgroup.com
